Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors
Satoshi Kitazawa(Takeda (Japan)), Takahito Hara(Takeda (Japan))
Cited by 34
Related Papers
Androgen Receptor and Invasion in Prostate Cancer
|Cancer Research|2008|114
Low tumor glutathione level as a sensitivity marker for glutamate‑cysteine ligase inhibitors
|Oncology Letters|2018|74